Partner David Hickerson was quoted in a World Intellectual Property Review article, “Trade relations: Sending in the big guns,” about whether the Trump administration is overreaching the scope of its trade tools in its fight against Chinese bad actors.
Hickerson said he believes the administration is using the March 2018 U.S. Trade Representative’s section 301 report into “China’s Acts and Policies on IP, Technology Transfer and Innovation,” to exert influence in trade negotiations. “If Trump imposes tariffs on all Chinese imports, as has been threatened, this will be an overreach of section 301,” he said.
Hickerson also said the International Trade Commission has used section 337 cases over the past two decades to target Chinese companies. “The number of cases filed against Chinese respondents exceeds the number of ITC filings against respondents from all other countries (excluding the U.S.) combined,” he added.
Hickerson said he believes the administration is using the March 2018 U.S. Trade Representative’s section 301 report into “China’s Acts and Policies on IP, Technology Transfer and Innovation,” to exert influence in trade negotiations. “If Trump imposes tariffs on all Chinese imports, as has been threatened, this will be an overreach of section 301,” he said.
Hickerson also said the International Trade Commission has used section 337 cases over the past two decades to target Chinese companies. “The number of cases filed against Chinese respondents exceeds the number of ITC filings against respondents from all other countries (excluding the U.S.) combined,” he added.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”